# Trade Mark Journal No.2026/013 27 March 2026

## WO0000001906655 (42)

Office of origin: United States of America

Date of International Registration:21 January 2026
Date of designation in the UK: 21 January 2026

International priority date claimed: 20 October 2025 (United States of America) (99452284)

Class 42
  Chemical research; biotechnology research; scientific research and development; pharmaceutical research and development; pharmaceutical drug development services.

Athira Pharma, Inc.

Representative: Kevin S. Costanza Seed Intellectual Property Law Group LLP, 701 5th Avenue, Suite 5400, Seattle WA 98104, UNITED STATES OF AMERICA